EXPRESSION OF PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR BY RAT MESOTHELIOMA INDUCED BY ASBESTOS

被引:1
|
作者
LENZ, SP
GREEN, FHY
MURPHY, PG
LEE, M
HART, DA
机构
[1] UNIV CALGARY,HSC,MCCAIG CTR JOINT INJURY & ARTHRITIS RES,JOINT INJURY & ARTHRITIS RES GRP,CALGARY T2N 4N1,AB,CANADA
[2] UNIV CALGARY,HSC,DEPT PATHOL,CALGARY T2N 1N4,ALBERTA,CANADA
[3] UNIV CALGARY,HSC,DEPT MED PHYSIOL,CALGARY T2N 1N4,ALBERTA,CANADA
关键词
ASBESTOS; MESOTHELIOMA; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR;
D O I
10.1016/0304-3835(93)90137-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have investigated the expression of plasminogen activators (PAs) and PA inhibitors (PAIs) by an asbestos-induced mesothelioma. Using zymographic, immunological and biochemical techniques it was demonstrated that cell lines derived from the tumor express high levels of PAI and low levels of a UK-like PA. Adherent and partially non-adherent variants of the mesothelioma expressed indistinguishable amounts of PAI and UK. Based on partial biochemical characterization, the PAI secreted by the mesothelioma cells was a set of PAIs which consisted of PAI-1 in addition to other species. These observations indicate that the difference in growth phenotype of the adherent and partially non-adherent lines was not due to detectable differences in PA and PAI expression.
引用
收藏
页码:119 / 127
页数:9
相关论文
共 50 条
  • [31] TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND FAST-ACTING PLASMINOGEN-ACTIVATOR INHIBITOR IN PLASMA
    VERHEIJEN, JH
    [J]. METHODS IN ENZYMOLOGY, 1988, 163 : 302 - 309
  • [32] THE MECHANISM OF THE REACTION BETWEEN HUMAN PLASMINOGEN-ACTIVATOR INHIBITOR-1 AND TISSUE PLASMINOGEN-ACTIVATOR
    LINDAHL, TL
    OHLSSON, PI
    WIMAN, B
    [J]. BIOCHEMICAL JOURNAL, 1990, 265 (01) : 109 - 113
  • [33] ITO CELLS SYNTHESIZE PLASMINOGEN-ACTIVATOR INHIBITOR-1 - REGULATION BY CORTICOSTEROIDS AND PLASMINOGEN-ACTIVATOR
    KNITTEL, T
    FELLMER, P
    RAMADORI, G
    [J]. GASTROENTEROLOGY, 1995, 108 (04) : A1100 - A1100
  • [34] HORMONAL-REGULATION OF PLASMINOGEN-ACTIVATOR AND PLASMINOGEN ACTIVATOR-INHIBITOR GENE-EXPRESSION IN RAT HEPATOCYTES
    GELEHRTER, TD
    HEATON, JH
    NEBES, VL
    MORRIS, SM
    [J]. CLINICAL RESEARCH, 1988, 36 (03): : A565 - A565
  • [35] THROMBIN AND PLASMINOGEN-ACTIVATOR INHIBITOR - RESPONSE
    COLUCCI, M
    SEMERARO, N
    [J]. BLOOD, 1990, 76 (04) : 853 - 854
  • [36] FIBRINOLYTIC THERAPY - PLASMINOGEN-ACTIVATOR INHIBITOR
    HONIGL, K
    PILGER, E
    STARK, G
    BERTUCH, H
    [J]. VASA-JOURNAL OF VASCULAR DISEASES, 1988, : 103 - 106
  • [37] THE INFLUENCE OF SURGERY ON PLASMINOGEN-ACTIVATOR INHIBITOR
    NEERSTRAND, H
    HEDNER, U
    LUTZEN, O
    HAUCH, O
    JORGENSEN, LN
    NERSTROM, H
    KOLLE, TR
    WILLEJORGENSEN, P
    [J]. THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 557 - 557
  • [38] PLASMINOGEN-ACTIVATOR INHIBITOR IN ACUTE STROKE
    BROCKMANN, MJ
    SCHWENDEMANN, G
    STIEF, TW
    [J]. MOLECULAR AND CHEMICAL NEUROPATHOLOGY, 1991, 14 (02) : 143 - 150
  • [39] TISSUE PLASMINOGEN-ACTIVATOR INHIBITOR IN THE EPIDERMIS
    HASHIMOTO, K
    KATAYAMA, I
    NISHIOKA, K
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 1985, 113 (05) : 523 - 527
  • [40] PLASMINOGEN-ACTIVATOR INHIBITOR IN PLASMA AND ARTERIOSCLEROSIS
    MATSUDA, T
    MORISHITA, E
    JOKAJI, H
    SAITO, M
    KUMABASHIRI, I
    AKAKURA, H
    UOTANI, C
    YAMAZAKI, M
    [J]. ATHEROSCLEROSIS III: RECENT ADVANCES IN ATHEROSCLEROSIS RESEARCH: THE THIRD SARATOGA INTERNATIONAL CONFERENCE ON ATHEROSCLEROSIS IN NEKOMA, 1995, 748 : 394 - 398